FibroBiologics (FBLG) Assets Average (2024 - 2026)

FibroBiologics (FBLG) has reported Assets Average for 3 consecutive years, with $6.9 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Assets Average fell 45.26% year-over-year to $6.9 million; the trailing twelve-month figure through Jun 2026 stood at $6.9 million (down 45.26% YoY), and the FY2025 full-year result was $13.0 million, down 7.79% from the prior year.
• Assets Average fell to $6.9 million in Q2 2026 per FBLG's latest filing, from $7.8 million in the prior quarter.
• Across five years, Assets Average topped out at $13.9 million in Q1 2025 and bottomed at $6.9 million in Q2 2026.
• Historically, Assets Average has averaged $10.7 million across 3 years, with a median of $10.7 million in 2024.
• The sharpest annual moves came in 2025 and 2026: Assets Average grew 24.73% in 2025, then plunged 45.26% in 2026.
• Over 3 years, Assets Average stood at $13.5 million in 2024, then sank by 31.77% to $9.2 million in 2025, then dropped by 24.48% to $6.9 million in 2026.
• According to Business Quant data, Assets Average over the past three periods registered $6.9 million, $7.8 million, and $9.2 million for Q2 2026, Q1 2026, and Q4 2025 respectively.